Nouscom raises €120M Series D to fund pivotal immunotherapy trial
The Swiss biotech plans to advance its lead therapy into a global registration study targeting Lynch Syndrome.
Topic
The earliest institutional rounds: who raises them, how big they are and who leads them.
The Swiss biotech plans to advance its lead therapy into a global registration study targeting Lynch Syndrome.
The company plans to use the new funding to scale sales teams and expand into Latin America and Asia.
The group posted consolidated operating revenue of ₹1.45 Lakh Cr and an ₹8,468 Cr net loss for FY26 following its reverse flip to India.
Ethiopian healthtech startup Medanit, launched in 2022, now serves 527 physicians and logged 1.2 million site visits since January.
The Nigerian startup introduced its UniBeta AI exam platform after closing an angel investment round.
Starlink joins OneWeb and Jio Satellite Communications with GMPCS licences, and Indian regulators say all three are at the same stage with security assessments ongoing.
The Indian apparel maker plans to expand from 25 to 150 retail stores and broaden its menswear catalog.
The Amsterdam-based startup secured fresh capital from Dutch tech operators and NL SportTech Ventures to modernize fitness business tools.
Rounds, investors and deadlines that matter. Daily, 5-minute read. Unsubscribe anytime.